Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin and ciprofloxacin for diabetic foot osteomyelitis
IRCT2016110830793N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- May 2016
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of clindamycin and ciprofloxacin in diabetic foot osteomyelitis (DFO), sponsored by Ardabil University of Medical Sciences. Started May 2016; status: completed.
02
Drugs
clindamycinciprofloxacin
03
Conditions
diabetic foot osteomyelitis (DFO)
Beyond the preview
Go deeper on IRCT2016110830793N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016110830793N1.